Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hamon

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
European Journal of Clinical Pharmacology|February 26, 2022
Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin geneDavid A Nielsen, Robrina Walker, David P Graham, et al.
Allergy|January 27, 2024
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapyMatthew F Wipperman, Kaitlyn M Gayvert, Amanda Atanasio, et al.
Journal of the American Academy of Dermatology|July 7, 2026
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension studyAlan D Irvine, Amy S Paller, Elaine C Siegfried, et al.
Journal of Lipid Research|July 11, 2020
Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearanceRene C Adam, Ivory J Mintah, Corey A Alexa-Braun, et al.
Allergy|May 15, 2026
Type-2-Inflammatory-Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 BlockadeJennifer D Hamilton, Manuel A R Ferreira, Wei Keat Lim, et al.
Ebiomedicine|September 13, 2024
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19Bei Wang, Jacquelynn Golubov, Erin M Oswald, et al.
Osteoarthritis and Cartilage Open|January 16, 2026
Identification of alkaline phosphatase as a putative biomarker of anti-NGF treatment-associated arthropathies: Machine learning-assisted analyses of clinical trial dataMatthew F Wipperman, Peter J Ehmann, Debra A G McIntyre, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptomeWei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.
Elife|April 30, 2024
Digital wearable insole-based identification of knee arthropathies and gait signatures using machine learningMatthew F Wipperman, Allen Z Lin, Kaitlyn M Gayvert, et al.
Science Translational Medicine|October 29, 2025
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthmaSeblewongel Asrat, Wei Keat Lim, Subhashini Srivatsan, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
European Journal of Clinical Pharmacology|February 26, 2022
Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin geneDavid A Nielsen, Robrina Walker, David P Graham, et al.
Allergy|January 27, 2024
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapyMatthew F Wipperman, Kaitlyn M Gayvert, Amanda Atanasio, et al.
Journal of the American Academy of Dermatology|July 7, 2026
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension studyAlan D Irvine, Amy S Paller, Elaine C Siegfried, et al.
Journal of Lipid Research|July 11, 2020
Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearanceRene C Adam, Ivory J Mintah, Corey A Alexa-Braun, et al.
Allergy|May 15, 2026
Type-2-Inflammatory-Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 BlockadeJennifer D Hamilton, Manuel A R Ferreira, Wei Keat Lim, et al.
Ebiomedicine|September 13, 2024
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19Bei Wang, Jacquelynn Golubov, Erin M Oswald, et al.
Osteoarthritis and Cartilage Open|January 16, 2026
Identification of alkaline phosphatase as a putative biomarker of anti-NGF treatment-associated arthropathies: Machine learning-assisted analyses of clinical trial dataMatthew F Wipperman, Peter J Ehmann, Debra A G McIntyre, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptomeWei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.
Elife|April 30, 2024
Digital wearable insole-based identification of knee arthropathies and gait signatures using machine learningMatthew F Wipperman, Allen Z Lin, Kaitlyn M Gayvert, et al.
Science Translational Medicine|October 29, 2025
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthmaSeblewongel Asrat, Wei Keat Lim, Subhashini Srivatsan, et al.
Pageof 10